Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04434040 |
|---|---|
| Brief Title: | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) |
| First Submitted : | June 14, 2020 |
| First Submitted that Met QC Criteria : | June 14, 2020 |
| First Posted : | June 16, 2020 |
| Last Update Submitted that Met QC Criteria : | January 22, 2024 |
| Last Update Posted : | January 23, 2024 |